BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06345729-completion@plaintrial.com
DTSTAMP:20261028T192548Z
DTSTART;VALUE=DATE:20310218
SUMMARY:A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Par
 ticipants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Pr
 ogrammed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (
 MK-1084-004/KANDLELIT-004) — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06345729
URL:https://plaintrial.com/trial/NCT06345729
END:VEVENT
END:VCALENDAR